IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $19.00K; Additional Paid in CapitalUSD $3.62B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $13.08M; Retained Earnings (Accumulated Deficit)USD $-2.90B.
- 2026-03-31: Common Stock, Value, IssuedUSD $18.00K; Additional Paid in CapitalUSD $3.56B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $12.65M; Retained Earnings (Accumulated Deficit)USD $-2.85B.
- 2025-12-31: Common Stock, Value, IssuedUSD $17.00K; Additional Paid in CapitalUSD $3.46B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $16.44M; Retained Earnings (Accumulated Deficit)USD $-2.78B.
- 2025-09-30: Common Stock, Value, IssuedUSD $16.00K; Additional Paid in CapitalUSD $3.39B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $16.10M; Retained Earnings (Accumulated Deficit)USD $-2.70B.
IOVANCE BIOTHERAPEUTICS, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Preferred Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Fair Value USD | Adjustments to Additional Paid in Capital, Other USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $19.00K | $3.62B | $13.08M | $-2.90B | $736.04M | 3 month · $11.89M 6 month · $23.56M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $18.00K | $3.56B | $12.65M | $-2.85B | $721.75M | 3 month · $11.67M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $17.00K | $3.46B | $16.44M | $-2.78B | $698.58M | 12 month · $60.90M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $16.00K | $3.39B | $16.10M | $-2.70B | $702.29M | 3 month · $11.75M 9 month · $49.21M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $14.00K | $3.29B | $20.86M | $-2.61B | $698.49M | 3 month · $14.48M 6 month · $37.45M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $14.00K | $3.26B | $6.29M | $-2.50B | $767.87M | 3 month · $22.97M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $13.00K | $3.10B | $-1.05M | $-2.38B | $710.40M | 12 month · $110.88M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $13.00K | $3.06B | $16.24M | $-2.31B | $773.46M | 3 month · $30.79M 9 month · $80.39M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $12.00K | $2.99B | $526.00K | $-2.22B | $768.54M | 3 month · $31.83M 6 month · $49.60M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $12.00K | $2.81B | $116.00K | $-2.13B | $680.02M | 3 month · $17.77M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $11.00K | $2.59B | $2.53M | $-2.01B | $584.61M | 12 month · $62.62M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $11.00K | $2.58B | $-9.10M | $-1.90B | $674.01M | 3 month · $15.82M 9 month · $48.23M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $9.00K | $2.36B | $325.00K | $-1.78B | $578.57M | 3 month · $16.74M 6 month · $32.41M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $9.00K | $2.34B | $-126.00K | $-1.68B | $666.88M | 3 month · $15.66M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $8.00K | $2.07B | $-902.00K | $-1.57B | $499.64M | 12 month · $84.02M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $7.00K | $1.86B | $-2.04M | $-1.46B | $393.74M | 3 month · $19.78M 9 month · $64.51M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $7.00K | $1.84B | $-2.70M | $-1.36B | $472.69M | 3 month · $22.47M 6 month · $44.73M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $7.00K | $1.82B | $-2.34M | $-1.26B | $551.99M | 3 month · $22.27M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $7.00K | $1.79B | $-601.00K | $-1.17B | $621.66M | 12 month · $69.77M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $7.00K | $1.77B | $-5.00K | $-1.07B | $698.33M | 3 month · $19.31M 9 month · $50.66M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $7.00K | $1.73B | $33.00K | $-986.99M | $744.41M | 3 month · $14.41M 6 month · $31.36M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $6.00K | $1.55B | $96.00K | $-905.64M | $647.43M | 3 month · $16.94M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $6.00K | $1.49B | $19.00K | $-830.19M | $656.50M | 12 month · $40.77M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $6.00K | $1.47B | $155.00K | $-761.80M | $711.84M | 3 month · $10.71M 9 month · $30.66M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $6.00K | $1.46B | $317.00K | $-703.23M | $758.31M | 3 month · $10.54M 6 month · $19.95M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $5.00K | $882.60M | $912.00K | $-640.21M | $243.31M | 3 month · $9.41M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $5.00K | $869.35M | $220.00K | $-570.61M | $298.97M | 12 month · $24.28M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | $5.00K | $239.00K | $861.86M | $-507.04M | $355.06M | 3 month · $6.60M 9 month · $18.87M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $5.00K | $372.00K | $854.60M | $-457.56M | $397.42M | 3 month · $6.43M 6 month · $12.27M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $5.00K | $844.79M | $138.00K | $-410.01M | $434.93M | 3 month · $5.85M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-01-01 | (m) | (m) | (m) | $300.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $5.00K | $838.98M | $-42.00K | $-372.76M | $466.19M | 12 month · $20.03M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | $4.00K | $594.46M | $-120.00K | $-340.19M | $254.16M | 3 month · $5.52M 9 month · $14.84M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | $4.00K | $576.92M | $-3.00K | $-306.36M | $270.57M | 3 month · $5.22M 6 month · $9.33M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $3.00K | $568.24M | (m) | $-275.69M | $292.56M | 3 month · $4.10M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $3.00K | $394.65M | $0.00 | $-249.18M | $145.48M | 12 month · $11.97M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | $3.00K | $388.76M | $0.00 | $-223.33M | $165.44M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $3.00K | $330.32M | $0.00 | $-201.18M | $129.15M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $3.00K | $327.67M | $2.00K | $-177.80M | $149.89M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $3.00K | $323.99M | $29.00K | $-157.12M | $166.92M | 12 month · $18.90M | (m) | (m) | (m) | (m) | (m) | 12 month · $49.45M |
| 2016-09-30 | $3.00K | $320.14M | $163.00K | $-141.43M | $179.13M | 9 month · $15.78M | (m) | (m) | (m) | (m) | (m) | 9 month · $-49.45M |
| 2016-06-30 | $3.00K | $311.27M | $78.00K | $-122.67M | $188.94M | (m) | (m) | (m) | (m) | 6 month · $1.07M | 6 month · $6.07M | (m) |
| 2016-03-31 | $2.00K | $209.73M | $68.00K | $-111.11M | $98.94M | (m) | $0.00 | (m) | (m) | 3 month · $296.00K | 3 month · $1.48M | (m) |
| 2015-12-31 | $2.00K | $208.19M | $48.00K | $-104.22M | $104.02M | 12 month · $6.75M | $0.00 | (m) | (m) | 12 month · $0.00 | 12 month · $6.75M | (m) |
| 2015-09-30 | $2.00K | $204.93M | $38.00K | $-95.84M | $109.37M | (m) | (m) | (m) | (m) | 9 month · $1.55M | 9 month · $4.22M | (m) |
| 2015-06-30 | $1.96K | $200.83M | $21.70K | $-88.23M | $112.87M | (m) | $4.00 | (m) | (m) | 6 month · $1.09M | 6 month · $2.30M | (m) |
| 2015-03-31 | $1.87K | $193.24M | (m) | $-81.86M | $111.63M | (m) | $4.00 | (m) | (m) | 3 month · $450.44K | 3 month · $1.02M | (m) |
| 2014-12-31 | $2.00K | $121.16M | $0.00 | $-76.56M | $44.84M | 12 month · $2.56M | $0.00 | (m) | (m) | (m) | 12 month · $2.56M | (m) |
| 2014-09-30 | $1.15K | (m) | (m) | $-71.70M | $16.16M | (m) | $6.00 | $87.61M | (m) | (m) | (m) | (m) |
| 2014-06-30 | $1.14K | (m) | (m) | $-68.90M | $17.38M | (m) | $6.00 | $86.03M | (m) | (m) | (m) | (m) |
| 2014-03-31 | $921.00 | (m) | (m) | $-66.79M | $16.81M | (m) | $13.00 | $83.35M | (m) | (m) | (m) | (m) |
| 2013-12-31 | $835.00 | $81.88M | (m) | $-64.53M | $17.60M | (m) | $17.00 | $81.88M | (m) | (m) | 12 month · $747.00K | 12 month · $0.00 |
| 2013-09-30 | $629.00 | (m) | (m) | $-44.57M | $-3.34M | (m) | (m) | $40.58M | (m) | (m) | (m) | (m) |
| 2013-06-30 | $556.00 | (m) | (m) | $-35.16M | $-2.77M | (m) | (m) | $31.74M | (m) | (m) | (m) | (m) |
| 2013-03-31 | $34.00 | (m) | (m) | $-31.73M | $-12.28M | (m) | (m) | $19.21M | (m) | (m) | (m) | (m) |
| 2012-12-31 | $34.00 | (m) | (m) | $-30.68M | $-11.32M | (m) | (m) | $19.12M | (m) | (m) | (m) | (m) |
| 2012-09-30 | $3.26K | (m) | (m) | $-34.15M | $-16.58M | (m) | (m) | $17.07M | (m) | (m) | (m) | (m) |
| 2012-06-30 | $3.26K | (m) | (m) | $-33.48M | $-16.62M | (m) | (m) | $16.36M | (m) | (m) | (m) | (m) |
| 2012-03-31 | $3.26K | (m) | (m) | $-33.15M | $-17.26M | (m) | (m) | $15.89M | (m) | (m) | (m) | (m) |
| 2011-12-31 | $3.25K | (m) | (m) | $-27.38M | $-12.78M | (m) | (m) | $14.59M | (m) | (m) | (m) | (m) |
| 2011-09-30 | $3.29K | (m) | (m) | $-19.02M | $-5.69M | (m) | (m) | $13.33M | (m) | (m) | (m) | (m) |
| 2011-06-30 | $3.24K | (m) | (m) | $-13.21M | $-1.40M | (m) | (m) | $11.80M | 6 month · $384.26K | (m) | (m) | (m) |
| 2010-12-31 | $3.07K | (m) | (m) | $-1.68M | $638.09K | (m) | (m) | $2.32M | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | (m) | (m) | $-13.49K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | (m) | (m) | $2.28K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-12-31 | (m) | (m) | (m) | (m) | $61.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-09-16 | (m) | (m) | (m) | (m) | $8.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |